LY3325656

SKU: orb1739475

Description

LY3325656 is a GPR142 agonist with demonstrated anti-diabetic efficacy in preclinical models, showing suitable ADME/PK for human use. It is the first molecule of its class to enter Phase 1 clinical trials for Type 2 diabetes, following studies confirming its in vitro receptor activation and in vivo glucose-lowering effects in animal studies.

Key Properties

• CAS Number: 1998714-25-2
• MW: 448.44
• Formula: C₂₁H₂₃F₃N₆O₂
• SMILES: CC1=C(N(C)C=N1)C=2NC(=NN2)[C@@H]3C[C@H](N(C(=O)C4=CC(C(F)(F)F)=CC=C4)C)CCO3
• Target: Others

Storage & Handling

• Storage: -20°C
• Expiration Date: 12 months from date of receipt.
• Disclaimer: For research use only

Compound Identifiers

PubChem CID

135205863